Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
Recursion (RXRX) Stock Surges 191% in 3 Months: Here's Why
09:09am, Thursday, 20'th Jul 2023
Recursion's (RXRX) shares rallied almost 191% over the past three months, owing to artificial intelligence-driven acquisitions and strategic collaborations to advance drug development.
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?
03:08pm, Wednesday, 19'th Jul 2023
The artificial intelligence (AI) trade has been blistering higher, but Wednesday featured an interesting surge. That's as shares of Recursion Pharmaceuticals (NASDAQ: RXRX ) are exploding higher on th
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
10:00am, Tuesday, 18'th Jul 2023
Schrödinger and Recursion Pharmaceuticals use AI to improve drug development. Neither one has proven its business model to be viable yet.
Recursion: Shaking Up The Biopharma Landscape With A Bold, Data-Driven Blueprint
05:04pm, Monday, 17'th Jul 2023
Recursion, a biopharma company, uses a data-driven approach to drug discovery, launching four clinical trials and planning a fifth in oncology. Recursion's software platform, the Recursion OS, is used
Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia)
05:51am, Friday, 14'th Jul 2023
Nvidia is investing $50 million in Recursion Pharmaceuticals. The two companies are also working together to use AI to speed up drug discovery.
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?
01:27pm, Thursday, 13'th Jul 2023
Recursion Pharmaceuticals (NASDAQ: RXRX ) stock is the talk of Wall Street lately. Indeed, RXRX soared more than 120% Wednesday after Nvidia (NASDAQ: NVDA ) announced it would invest $50 million into
Recursion (RXRX) Up on $50M NVDA Investment for AI Drug Discovery
12:36pm, Thursday, 13'th Jul 2023
Recursion (RXRX) soars on receiving an investment worth $50 million from Nivida for drug development using artificial intelligence.
Nvidia and Recursion Pharmaceuticals team up on AI-based biotech collaboration
03:21am, Thursday, 13'th Jul 2023
Tech giant NVIDIA Corporation (NASDAQ:NVDA) has dedicated US$50mln to a multi-year collaboration with US-listed biotech company Recursion Pharmaceuticals to develop AI-based software for improving pat
Recursion CEO Chris Gibson: There's real opportunity to leverage A.I. to speed up drug development
06:40pm, Wednesday, 12'th Jul 2023
Chris Gibson, Recursion CEO, joins 'Closing Bell Overtime' to talk the company's stock pop after announcing an A.I. deal with Nvidia, the utilization of A.I.
Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket
04:55pm, Wednesday, 12'th Jul 2023
Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday.
RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring
03:33pm, Wednesday, 12'th Jul 2023
Confirming the ongoing fervor for all things artificial intelligence (AI), shares of biotechnology firm Recursion Pharmaceuticals (NASDAQ: RXRX ) are soaring on Wednesday. What has catalyzed the massi
Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery
03:06pm, Wednesday, 12'th Jul 2023
Recursion Pharmaceuticals stock soared as much as 121% on Wednesday after it received an investment from Nvidia. Nvidia said it would invest $50 million in the company as it works to use AI for drug d
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
02:42pm, Wednesday, 12'th Jul 2023
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.
Recursion Pharmaceuticals stock soars following $50 million investment from AI chipmaker Nvidia
12:10pm, Wednesday, 12'th Jul 2023
Recursion Pharmaceuticals Inc. RXRX, +75.96% shares soared Wednesday after the drug developer said that graphics processing unit maker Nvidia Corp. NVDA, +2.54% invested $50 million in the company to
Why Shares of Recursion Pharmaceuticals Are Skyrocketing Wednesday
12:07pm, Wednesday, 12'th Jul 2023
Recursion focuses on drug discovery through machine learning. The company has nine programs in its pipeline.
